Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 5
1956 5
1957 12
1958 22
1959 16
1960 18
1961 21
1962 27
1963 95
1964 144
1965 60
1966 60
1967 82
1968 106
1969 82
1970 79
1971 81
1972 69
1973 69
1974 69
1975 60
1976 64
1977 65
1978 54
1979 44
1980 54
1981 55
1982 46
1983 57
1984 58
1985 60
1986 50
1987 56
1988 44
1989 66
1990 57
1991 60
1992 61
1993 42
1994 59
1995 72
1996 75
1997 64
1998 70
1999 77
2000 78
2001 74
2002 57
2003 40
2004 56
2005 57
2006 53
2007 34
2008 51
2009 39
2010 43
2011 42
2012 54
2013 57
2014 51
2015 63
2016 47
2017 51
2018 38
2019 53
2020 72
2021 45
Text availability
Article attribute
Article type
Publication date

Search Results

3,596 results
Results by year
Filters applied: . Clear all
Page 1
Thiotepa.
National Toxicology Program. National Toxicology Program. Rep Carcinog. 2011;12:406-7. Rep Carcinog. 2011. PMID: 21863106 Free article. No abstract available.
Thiotepa.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risks Hum. 1990;50:123-41. IARC Monogr Eval Carcinog Risks Hum. 1990. PMID: 2127291 Free PMC article. Review. No abstract available.
Thiotepa.
Betcher DL, Burnham N. Betcher DL, et al. J Pediatr Oncol Nurs. 1991 Apr;8(2):95-7. doi: 10.1177/104345429100800242. J Pediatr Oncol Nurs. 1991. PMID: 1904247 No abstract available.
Thiotepa.
[No authors listed] [No authors listed] Rep Carcinog. 2004;11:III249-50. Rep Carcinog. 2004. PMID: 21089968 No abstract available.
Chemistry, pharmacology and pharmacokinetics of N,N',N" -triethylenethiophosphoramide (ThioTEPA).
Maanen MJ, Smeets CJ, Beijnen JH. Maanen MJ, et al. Cancer Treat Rev. 2000 Aug;26(4):257-68. doi: 10.1053/ctrv.2000.0170. Cancer Treat Rev. 2000. PMID: 10913381 Review.
In recent years greater insight has been obtained into the metabolism of thioTEPA, but there is still a gap between the total urinary excretion of thioTEPA and metabolites and the alkylating activity. ...An overview is given of the chemistry, pharmacology, clinical …
In recent years greater insight has been obtained into the metabolism of thioTEPA, but there is still a gap between the total urinary …
Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
de Lemos ML, Monfared S, Denyssevych T, Hamata L, Jennings S, Thiessen B, Smith S, Waterhouse D. de Lemos ML, et al. J Oncol Pharm Pract. 2009 Mar;15(1):45-52. doi: 10.1177/1078155208096902. Epub 2008 Sep 4. J Oncol Pharm Pract. 2009. PMID: 18772215 Review.
There was no apparent impact of thiotepa concentration on the pH values of the final preparations, irrespective of the diluent used. ...Osmolality was increased with increased concentrations in all except methotrexate mixed in SWFI and thiotepa mixed in normal salin …
There was no apparent impact of thiotepa concentration on the pH values of the final preparations, irrespective of the diluent used. …
Management of pterygia: should thiotepa be used?
Olander K, Haik KG, Haik GM. Olander K, et al. Ann Ophthalmol. 1978 Jul;10(7):853-62. Ann Ophthalmol. 1978. PMID: 98089 Review.
The following report is a review of the literature from 1960 to 1977 on the role of thiotepa in treatment of pterygium, with emphasis on the complications of thiotepa administration. ...The main reported complication from thiotepa's use has been depigmentatio …
The following report is a review of the literature from 1960 to 1977 on the role of thiotepa in treatment of pterygium, with emphasis …
Effects of thioTEPA chemotherapy on cognition and motor coordination.
Alexander TC, Kiffer F, Groves T, Anderson J, Wang J, Hayar A, Chen MT, Rodriguez A, Allen AR. Alexander TC, et al. Synapse. 2019 Jun;73(6):e22085. doi: 10.1002/syn.22085. Epub 2019 Mar 14. Synapse. 2019. PMID: 30586195 Free PMC article.
Male mice were given three intraperitoneal injections of thioTEPA. Five weeks later, the mice underwent behavior testing, and brains were collected for Golgi staining and cytokine analysis. ...Also, dendritic arborization and length were decreased after chemotherapy treatm …
Male mice were given three intraperitoneal injections of thioTEPA. Five weeks later, the mice underwent behavior testing, and brains …
Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma.
Kokolo MB, Fergusson D, O'Neill J, Tay J, Tinmouth AT, Stewart D, Bredeson C. Kokolo MB, et al. Leuk Lymphoma. 2014 Dec;55(12):2712-20. doi: 10.3109/10428194.2014.889825. Epub 2014 Mar 26. Leuk Lymphoma. 2014. PMID: 24491026 Review.
So data synthesis focused on the 226 patients who received thiotepa. Based on pooled estimates, 75.9% of thiotepa-treated patients achieved a complete remission (95% confidence interval [CI] = 67.5-82.8), and 61.7% had a progression-free survival for up to 125 month …
So data synthesis focused on the 226 patients who received thiotepa. Based on pooled estimates, 75.9% of thiotepa-treated pati …
3,596 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page